Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Annals of the Royal College of Surgeons of England|May 23, 2012
Prolonged survival after surgical management of metastases in malignant melanoma: three case reportsS R Whitaker, S J Houston
The Nursing Clinics of North America|September 1, 1992
Psychosocial implications of lung cancerS J Houston, J A Kendall
Clinical Orthopaedics and Related Research|March 1, 1995
The systemic treatment of bone metastasesS J Houston, R D Rubens
Hospital Medicine (London, England : 1998)|July 20, 2005
Bisphosphonates' use in metastatic bone diseaseR A Hubner, S J Houston
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
The influence of adjuvant chemotherapy on outcome after relapse for patients with breast cancerS J Houston, M A Richards, A E Bentley, et al.
British Journal of Cancer|March 31, 1999
Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancerS J Houston, T A Plunkett, D M Barnes, et al.
The British Journal of Surgery|December 1, 1994
Combination chemotherapy with epirubicin, cisplatin and 5-fluorouracil for the palliation of advanced gastric and oesophageal adenocarcinomaM S Highley, F X Parnis, G A Trotter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Impact of tamoxifen on the pharmacokinetics and endocrine effects of the aromatase inhibitor letrozole in postmenopausal women with breast cancerM Dowsett, C Pfister, S R Johnston, et al.
British Journal of Cancer|February 1, 1996
Therapeutic effects of the aromatase inhibitor fadrozole hydrochloride in advanced breast cancerH R Bonnefoi, I E Smith, M Dowsett, et al.
Anti-Cancer Drugs|March 10, 1998
Vorozole (Rivizor): an active and well tolerated new aromatase inhibitor for the treatment of advanced breast cancer patients with prior tamoxifen exposure. Investigational Drug Branch of the European Organization for Research and Treatment of Cancer (EORTC) Breast Cancer Cooperative GroupR Paridaens, J A Roy, M Nooij, et al.
Pageof 2